Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Britannia Life Sciences AGM Information 2026

Jan 12, 2026

45110_rns_2026-01-12_b32f18b8-6706-4223-a70c-1be87b3ad4cb.pdf

AGM Information

Open in viewer

Opens in your device viewer

January 12, 2026

ODYSSEY

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject: Britannia Life Sciences Inc. (the "Issuer") Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

Meeting Type: Annual General Meeting
Meeting Date: February 24, 2026
Record Date for Notice of Meeting: January 16, 2026
Record Date for Voting (if applicable): January 16, 2026
Beneficial Ownership Determination Date: January 16, 2026
Class of Securities Entitled to Vote: COMMON SHARES
ISIN: CA11042D1087
Issuer sending proxy materials directly to NOBOs: No
Issuer paying for delivery to OBOs: No
Notice and Access for Beneficial Holders: No
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company
as agent for Britannia Life Sciences Inc.